Christina M Theodorou1, A Francois Trappey2, Carl A Beyer3, Kaeli J Yamashiro3, Shinjiro Hirose3, Joseph M Galante3, Alana L Beres3, Jacob T Stephenson4. 1. University of California Davis Medical Center, Department of Surgery, Sacramento, CA. Electronic address: ctheodorou@ucdavis.edu. 2. University of Texas Health Sciences Center Houston, Department of Pediatric Surgery, Houston, TX. 3. University of California Davis Medical Center, Department of Surgery, Sacramento, CA. 4. University of California Davis Medical Center, Department of Surgery, Sacramento, CA; Uniformed Services University of Health Sciences, Department of Pediatric Surgery, Bethesda, MD.
Abstract
BACKGROUND: Trauma is the leading cause of death in children. Resuscitative endovascular balloon occlusion of the aorta (REBOA) provides temporary hemorrhage control, but its potential benefit has not been assessed in children. We hypothesized that there are pediatric patients who may benefit from REBOA. METHODS: Trauma patients <18 years old at a level 1 pediatric trauma center between 2009 and 2019 were queried for deaths, pre-hospital cardiac arrest, massive transfusion protocol activation, transfusion requirement, or hemorrhage control surgery. These patients defined the cohort of severely injured patients. From this cohort, patients with intraabdominal injuries for which REBOA may provide temporary hemorrhage control were identified, including solid organ injury necessitating intervention, vascular injury, or pelvic hemorrhage. RESULTS: There were 239 severely injured patients out of 6538 pediatric traumas. Of these, 38 had REBOA-amenable injuries (15.9%) with 34.2% mortality, accounting for 10.2% of all pediatric trauma deaths at one center. Eleven patients with REBOA-amenable injuries had TBI (28.9%). Patients with REBOA-amenable injuries represented 0.6% of all pediatric traumas. CONCLUSION: Nearly 20% of severely injured pediatric patients could potentially benefit from REBOA. The overall proportion of pediatric patients with REBOA-amenable injuries is similar to adult studies. TYPE OF STUDY: Retrospective comparative study. LEVEL OF EVIDENCE: Level III.
BACKGROUND: Trauma is the leading cause of death in children. Resuscitative endovascular balloon occlusion of the aorta (REBOA) provides temporary hemorrhage control, but its potential benefit has not been assessed in children. We hypothesized that there are pediatric patients who may benefit from REBOA. METHODS: Trauma patients <18 years old at a level 1 pediatric trauma center between 2009 and 2019 were queried for deaths, pre-hospital cardiac arrest, massive transfusion protocol activation, transfusion requirement, or hemorrhage control surgery. These patients defined the cohort of severely injured patients. From this cohort, patients with intraabdominal injuries for which REBOA may provide temporary hemorrhage control were identified, including solid organ injury necessitating intervention, vascular injury, or pelvic hemorrhage. RESULTS: There were 239 severely injured patients out of 6538 pediatric traumas. Of these, 38 had REBOA-amenable injuries (15.9%) with 34.2% mortality, accounting for 10.2% of all pediatric trauma deaths at one center. Eleven patients with REBOA-amenable injuries had TBI (28.9%). Patients with REBOA-amenable injuries represented 0.6% of all pediatric traumas. CONCLUSION: Nearly 20% of severely injured pediatric patients could potentially benefit from REBOA. The overall proportion of pediatric patients with REBOA-amenable injuries is similar to adult studies. TYPE OF STUDY: Retrospective comparative study. LEVEL OF EVIDENCE: Level III.
Authors: Anders J Davidson; Rachel M Russo; Viktor A Reva; Megan L Brenner; Laura J Moore; Chad Ball; Eileen Bulger; Charles J Fox; Joseph J DuBose; Ernest E Moore; Todd E Rasmussen Journal: J Trauma Acute Care Surg Date: 2018-01 Impact factor: 3.313
Authors: Patrizio Petrone; Aida Pérez-Jiménez; Martín Rodríguez-Perdomo; Collin E M Brathwaite; D'Andrea K Joseph Journal: Am Surg Date: 2019-06-01 Impact factor: 0.688
Authors: Giovanni A Campagna; Megan E Cunningham; Jose A Hernandez; Alex Chau; Adam M Vogel; Bindi J Naik-Mathuria Journal: J Pediatr Surg Date: 2020-02-01 Impact factor: 2.545
Authors: Megan Brenner; William Teeter; Melanie Hoehn; Jason Pasley; Peter Hu; Shiming Yang; Anna Romagnoli; Jose Diaz; Deborah Stein; Thomas Scalea Journal: JAMA Surg Date: 2018-02-01 Impact factor: 14.766